Literature DB >> 17901116

The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse.

Maarten D de Boer1, Anna Selby, Philip Atherton, Ken Smith, Olivier R Seynnes, Constantinos N Maganaris, Nicola Maffulli, Tomas Movin, Marco V Narici, Michael J Rennie.   

Abstract

We hypothesized that rates of myofibrillar and patellar tendon collagen synthesis would fall over time during disuse, the changes being accompanied in muscle by decreases in focal adhesion kinase (FAK) phosphorylation and in gene expression for proteolytic enzymes. We studied nine men (22 +/- 4 years, BMI 24 +/- 3 kg m(-2) (means +/- s.d.) who underwent unilateral lower leg suspension for 23 days; five were studied between 0 and 10 days and four between 10 and 21 days. Muscle and tendon biopsies were taken in the postabsorptive state at days 0, 10 and 21 for measurement of protein synthesis, gene expression and protein phosphorylation. Muscle cross-sectional area decreased by 5.2% at 14 days and 10.0% (both P < 0.001), at 23 days, i.e. 0.5% day(-1), whereas tendon dimensions were constant. Rates of myofibrillar protein synthesis fell (P < 0.01) from 0.047% h(-1) at day 0 to 0.022% h(-1) at 10 days without further changes. Tendon collagen synthetic rates also fell (P < 0.01), from 0.052 to 0.023% h(-1) at 10 days and then to 0.010% h(-1) at 21 days. FAK phosphorylation decreased 30% (P < 0.01) at 10 days. No changes occurred in the amounts/phosphorylation of PKB-P70s6k-mTOR pathway components. Expression of mRNA for MuRF-1 increased approximately 3-fold at 10 days without changes in MAFbx or tripeptidyl peptidase II mRNA, but all decreased between 10 and 21 days. Thus, both myofibrillar and tendon protein synthetic rates show progressive decreases during 21 days of disuse; in muscle, this is accompanied by decreased phosphorylation of FAK, with no marked increases in genes for proteolytic enzymes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901116      PMCID: PMC2375459          DOI: 10.1113/jphysiol.2007.142828

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

Authors:  M D Gomes; S H Lecker; R T Jagoe; A Navon; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Muscle ubiquitin m-rNA levels in patients with end-stage renal disease on maintenance hemodialysis.

Authors:  Maurizio Bossola; Maurizio Muscaritoli; Paola Costelli; Giuseppe Nanni; Luigi Tazza; Nicola Panocchia; Silvia Busquets; Josef Argiles; Francisco J Lopez-Soriano; Gabriella Grieco; Francesco M Baccino; Filippo Rossi Fanelli; Marco Castagneto; Giovanna Luciani
Journal:  J Nephrol       Date:  2002 Sep-Oct       Impact factor: 3.902

4.  Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy.

Authors:  R Thomas Jagoe; Christopher P F Redfern; Russell G Roberts; G John Gibson; Timothy H J Goodship
Journal:  Clin Sci (Lond)       Date:  2002-03       Impact factor: 6.124

5.  Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass.

Authors:  Simon W Jones; Roger J Hill; Philip A Krasney; Barbara O'Conner; Nicholas Peirce; Paul L Greenhaff
Journal:  FASEB J       Date:  2004-04-14       Impact factor: 5.191

6.  Transcriptional pathways associated with skeletal muscle disuse atrophy in humans.

Authors:  Yi-Wen Chen; Chris M Gregory; Mark T Scarborough; Rongye Shi; Glenn A Walter; Krista Vandenborne
Journal:  Physiol Genomics       Date:  2007-09-05       Impact factor: 3.107

7.  Time course of muscular, neural and tendinous adaptations to 23 day unilateral lower-limb suspension in young men.

Authors:  Maarten D de Boer; Constantinos N Maganaris; Olivier R Seynnes; Michael J Rennie; Marco V Narici
Journal:  J Physiol       Date:  2007-07-26       Impact factor: 5.182

8.  Proteasome production in human muscle during nutritional inhibition of myofibrillar protein degradation.

Authors:  Irwin G Brodsky; Dennis Suzara; Mikhail Furman; Paul Goldspink; G Charles Ford; K Sreekumaran Nair; Jayme Kukowski; Sheryl Bedno
Journal:  Metabolism       Date:  2004-03       Impact factor: 8.694

9.  Sodium bicarbonate treatment and ubiquitin gene expression in acidotic human subjects with chronic renal failure.

Authors:  R G Roberts; C P F Redfern; K A Graham; K Bartlett; R Wilkinson; T H J Goodship
Journal:  Eur J Clin Invest       Date:  2002-07       Impact factor: 4.686

Review 10.  Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading.

Authors:  Michael Kjaer
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

View more
  114 in total

1.  Non-uniform displacement within the Achilles tendon during passive ankle joint motion.

Authors:  Anton Arndt; Ann-Sophie Bengtsson; Michael Peolsson; Alf Thorstensson; Tomas Movin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-27       Impact factor: 4.342

2.  Contrarily to whey and high protein diets, dietary free leucine supplementation cannot reverse the lack of recovery of muscle mass after prolonged immobilization during ageing.

Authors:  Hugues Magne; Isabelle Savary-Auzeloux; Carole Migné; Marie-Agnès Peyron; Lydie Combaret; Didier Rémond; Dominique Dardevet
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

Review 3.  Disuse of the musculo-skeletal system in space and on earth.

Authors:  M V Narici; M D de Boer
Journal:  Eur J Appl Physiol       Date:  2010-07-09       Impact factor: 3.078

4.  Lack of muscle recovery after immobilization in old rats does not result from a defect in normalization of the ubiquitin-proteasome and the caspase-dependent apoptotic pathways.

Authors:  Hugues Magne; Isabelle Savary-Auzeloux; Emilie Vazeille; Agnès Claustre; Didier Attaix; Listrat Anne; Santé-Lhoutellier Véronique; Gatellier Philippe; Dominique Dardevet; Lydie Combaret
Journal:  J Physiol       Date:  2010-11-29       Impact factor: 5.182

5.  Collagen network strengthening following cyclic tensile loading.

Authors:  Monica E Susilo; Jeffrey A Paten; Edward A Sander; Thao D Nguyen; Jeffrey W Ruberti
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

6.  Letter to the Editor on the Journal Club article by Barker and Traber.

Authors:  Michael J Rennie; Philip Atherton; Anna Selby; Kenneth Smith; Marco Narici; Maarten de Boer; Stuart Phillips; Elisa Glover
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

7.  Effect of 5 weeks horizontal bed rest on human muscle thickness and architecture of weight bearing and non-weight bearing muscles.

Authors:  Maarten D de Boer; Olivier R Seynnes; Pietro E di Prampero; Rado Pisot; Igor B Mekjavić; Gianni Biolo; Marco V Narici
Journal:  Eur J Appl Physiol       Date:  2008-03-05       Impact factor: 3.078

Review 8.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

9.  Relationship of changes in strain rate indices estimated from velocity-encoded MR imaging to loss of muscle force following disuse atrophy.

Authors:  Vadim Malis; Usha Sinha; Robert Csapo; Marco Narici; Shantanu Sinha
Journal:  Magn Reson Med       Date:  2017-05-30       Impact factor: 4.668

10.  Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion.

Authors:  Elisa I Glover; Stuart M Phillips; Bryan R Oates; Jason E Tang; Mark A Tarnopolsky; Anna Selby; Kenneth Smith; Michael J Rennie
Journal:  J Physiol       Date:  2008-10-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.